This video interview series will focus on in-depth discussions of recent clinical trials in hepatobiliary and pancreas cancers and their effect on multimodality regimens. We will use representative cases to foster a discussion of the details of the relevant clinical trials.

Series Objectives:

• Learn more about HPB Clinical Trials
• Discuss ways to integrate HPB Clinical Trials into clinical practice

This activity will focus on an in-depth discussion of recent clinical trials on Hepatocellular Carcinoma. The faculty will use representative cases to foster a discussion of the details of the relevant clinical trials. 

Goals/Objectives:

• Review previous trials for best practices
• Review ongoing trials for future clinical practice directions

The faculty for this activity are below:

Moderators:

Julie Hallet, MD, M.Sc.
Associate Professor of Surgery
University of Toronto
Sunnybrook Health Sciences Centre 

Aslam Ejaz, MD, MPH
Assistant Professor of Surgery
Section Lead – Hepato-pancreato-biliary and GI Surgery
The Ohio State University– James Cancer Hospital 

Panelists: 

Emily Winslow, MD
Professor of Surgery
Regional Chief of Hepatopancticobiliary Surgery
MedStar Health

Adam Yopp, MD
Associate Professor of Surgery
Chief of the Division of Surgical Oncology 
UT Southwestern Medical Center

Mark Yarchoan, MD
Associate Professor of Oncology
Johns Hopkins Medicine

Grainne O'Kane, MB, BCH, BAO, MRCPI, MD
Clinical Associate Professor of Medicine
Trinity St. James’s Cancer Institute,Dublin
Princess Margaret Cancer Centre - UHN